A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00627627
Recruitment Status : Withdrawn (Redirect focus of the indication)
First Posted : March 3, 2008
Last Update Posted : February 3, 2010
Information provided by:
MedImmune LLC

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : February 2010
  Study Completion Date : No date given